Nelarabine
Arranon, Atriance (nelarabine) is a small molecule pharmaceutical. Nelarabine was first approved as Arranon on 2005-10-28. It is used to treat t-cell leukemia in the USA. It has been approved in Europe to treat precursor t-cell lymphoblastic leukemia-lymphoma.
| Trade Name | Atriance |
|---|---|
| Common Name | Nelarabine |
| Indication | precursor t-cell lymphoblastic leukemia-lymphoma, t-cell leukemia |
| Drug Class | Antineoplastics (arabinofuranosyl derivatives) |
